BRIEF

on INTRASENSE (EPA:ALINS)

Intrasense: Revenue growth of 43% by 2025

Stock price chart of INTRASENSE (EPA:ALINS) showing fluctuations.

Intrasense has announced a 43% increase in its 2025 revenue, reaching €3.2 million, in line with its objectives. This performance is primarily due to the international momentum of the Myrian® solution. The company recorded sales of €1.1 million in France and €1.4 million in Europe.

Although its business in China is declining, Intrasense is strengthening its product portfolio with certifications for Myrian® and other innovative solutions. The company is strategically positioning itself on AI marketplaces, having signed a significant agreement with deepc.

Intrasense plans to maintain its growth in 2026 thanks to a secure order book of €6.1 million. Presentations at medical conferences are planned to increase its visibility.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all INTRASENSE news